Diffusion Pharmaceuticals Inc. (DFFN) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 37 transactions totaling $39.1K, demonstrating a bullish sentiment with $39.1K in net insider flow. The most recent transaction on Jun 30, 2023 involved a transaction of 85 shares valued at $0.
No significant insider buying has been recorded for DFFN in the recent period.
No significant insider selling has been recorded for DFFN in the recent period.
Based on recent SEC filings, insider sentiment for DFFN is bullish with an Insider Alignment Score of 100/100 and a net flow of $39.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Diffusion Pharmaceuticals Inc. (DFFN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading DFFN stock, having executed 37 transactions in the past 90 days. The most active insider is Jane H. Hollingsworth (Executive), who has made 11 transactions totaling $20.0K.
Get notified when executives and directors at DFFN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | M. Lanchoney Diana | Executive | Disposition | 85 | $N/A | $0 | |
| Jun 30, 2023 | M. Lanchoney Diana | Executive | Option Exercise | 232 | $N/A | $0 | |
| May 31, 2023 | H. Hollingsworth Jane | Executive | Disposition | 68 | $N/A | $0 | |
| May 31, 2023 | H. Hollingsworth Jane | Executive | Option Exercise | 183 | $N/A | $0 | |
| Mar 31, 2023 | M. Lanchoney Diana | Executive | Option Exercise | 232 | $N/A | $0 | |
| Mar 31, 2023 | M. Lanchoney Diana | Executive | Disposition | 85 | $N/A | $0 | |
| Feb 28, 2023 | H. Hollingsworth Jane | Executive | Disposition | 68 | $N/A | $0 | |
| Feb 28, 2023 | H. Hollingsworth Jane | Executive | Option Exercise | 183 | $N/A | $0 | |
| Jan 31, 2023 | Joseph Cobuzzi Robert Jr | Executive | Disposition | 121 | $N/A | $0 | |
| Jan 31, 2023 | Joseph Cobuzzi Robert Jr | Executive | Option Exercise | 327 | $N/A | $0 | |
| Nov 30, 2022 | H. Hollingsworth Jane | Executive | Option Exercise | 183 | $N/A | $0 | |
| Nov 30, 2022 | H. Hollingsworth Jane | Executive | Disposition | 68 | $N/A | $0 | |
| Oct 31, 2022 | Joseph Cobuzzi Robert Jr | Executive | Disposition | 121 | $N/A | $0 | |
| Oct 31, 2022 | Joseph Cobuzzi Robert Jr | Executive | Option Exercise | 327 | $N/A | $0 | |
| Aug 31, 2022 | H. Hollingsworth Jane | Executive | Option Exercise | 183 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $39.1K | 88.7% |
Conversion(C) | 2 | $5.0K | 11.3% |
Disposition(D) | 13 | $0 | 0.0% |
Exercise(M) | 14 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Diffusion Pharmaceuticals Inc. are accumulating shares at an accelerated pace. With 5 insiders making 37 transactions totaling $39.1K in purchases versus $0 in sales, the net buying activity of $39.1K signals strong executive confidence. Jane H. Hollingsworth (Executive) leads the buying activity with $20.0K in transactions across all time.